Counting the number of patients on treatment is no longer enough. For years even the friendliest critics of the global struggle against AIDS have pointed out that this metric unfairly neglects the people who are not put on treatment and then die, largely because their deaths are uncounted except in so far as they increase the treatment “coverage rate.” This diverts attention from the challenge of assuring that patients are retained on treatment and remain alive and healthy, rather than failing treatment and dying, sometimes after only a few months.
CGD Policy Blogs
There is a growing paradox on the US aid transparency front. The US government is simultaneously home to the world’s most open and most opaque development agencies. And the chasm between them has grown wider over the last year. That’s our main takeaway from Publish What You Fund’s (PWYF) latest Aid Transparency Index rankings of 67 major donor organizations.
It appears that the worst kept secret in Washington is out: Ambassador Goosby is expected to step down as Global AIDS Coordinator later this year. As CGD has done for similar leadership transitions, we are working on a report to examine the future direction of PEPFAR and consider which tasks PEPFAR’s next leader should put near the top of the program’s list of priorities. One preliminary conclusion: Goosby’s successor will certainly face programmatic challenges, but the political ones may prove to be more difficult.
PEPFAR deserves to be commended for its efforts to define key measurable outcomes for its orphans and vulnerable children (OVC) portfolio. Approximately 17 million children worldwide have lost one or both parents due to HIV/AIDS. In response, PEPFAR has earmarked 10% of its annual program funds to help mitigate the psychological and developmental effects this loss can have on children.